Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 3.1 EX-3.1
- 3.2 EX-3.2
- 3.3 EX-3.3
- 3.4 EX-3.4
- 3.6 EX-3.6
- 4.1 EX-4.1
- 4.2 EX-4.2
- 4.3 EX-4.3
- 4.4 EX-4.4
- 10.1 EX-10.1
- 10.2 EX-10.2
- 10.3 EX-10.3
- 10.4 EX-10.4
- 10.5 EX-10.5
- 10.6 EX-10.6
- 10.7 EX-10.7
- 10.13 EX-10.13
- 10.14 EX-10.14
- 10.15 EX-10.15
- 10.16 EX-10.16
- 10.17 EX-10.17
- 10.18 EX-10.18
- 10.19 EX-10.19
- 10.20 EX-10.20
- 10.21 EX-10.21
- 10.22 EX-10.22
- 10.23 EX-10.23
- 10.24 EX-10.24
- 10.25 EX-10.25
- 10.26 EX-10.26
- 10.27 EX-10.27
- 10.28 EX-10.28
- 10.29 EX-10.29
- 10.30 EX-10.30
- 16.1 EX-16.1
- 21.1 EX-21.1
- 23.1 EX-23.1
- 99.1 EX-99.1
AXNX similar filings
Filing view
External links
Exhibit 16.1
October 5, 2018
U.S. Securities and Exchange Commission
100 F. Street, N.E.
Washington, D.C. 20549
Commissioners:
We have read the section under the heading “Changes in and Disagreements with Accountants on Accounting and Financial Disclosure” included in the Registration Statement on FormS-1 of Axonics Modulation Technologies, Inc. to be filed on or about October 5, 2018 and are in agreement with the statements contained therein concerning our firm.
We hereby consent to the filing of this letter as an exhibit to the foregoing FormS-1.
Sincerely,
/S/ PETERSON SULLIVAN LLP
Seattle, Washington